Report Cover

Global Bevacizumab Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026


The Bevacizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Bevacizumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Bevacizumab market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Bevacizumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Avastin (bevacizumab)
    Mvasi (bevacizumab-awwb)

Market segment by Application can be divided into
    Cancer
    Eye Diease

The key market players for global Bevacizumab market are listed below:
    Genentech
    Amgen

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
    1.1 Bevacizumab Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Bevacizumab Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Avastin (bevacizumab)
        1.2.3 Mvasi (bevacizumab-awwb)
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Bevacizumab Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Cancer
        1.3.3 Eye Diease
    1.4 Global Bevacizumab Market Size & Forecast
        1.4.1 Global Bevacizumab Sales in Value (2016-2026))
        1.4.2 Global Bevacizumab Sales in Volume (2016-2026)
        1.4.3 Global Bevacizumab Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Bevacizumab Production Capacity Analysis
        1.5.1 Global Bevacizumab Total Production Capacity (2016-2026)
        1.5.2 Global Bevacizumab Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Bevacizumab Market Drivers
        1.6.2 Bevacizumab Market Restraints
        1.6.3 Bevacizumab Trends Analysis
2 Manufacturers Profiles
    2.1 Genentech
        2.1.1 Genentech Details
        2.1.2 Genentech Major Business
        2.1.3 Genentech Bevacizumab Product and Services
        2.1.4 Genentech Bevacizumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Bevacizumab Product and Services
        2.2.4 Amgen Bevacizumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Bevacizumab Sales by Manufacturer
    3.1 Global Bevacizumab Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Bevacizumab Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Bevacizumab
    3.4 Market Concentration Rate
        3.4.1 Top 3 Bevacizumab Manufacturer Market Share
        3.4.2 Top 6 Bevacizumab Manufacturer Market Share
    3.5 Global Bevacizumab Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Bevacizumab Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Bevacizumab Market Size by Region
        4.1.1 Global Bevacizumab Sales in Volume by Region (2016-2026)
        4.1.2 Global Bevacizumab Revenue by Region (2016-2026)
    4.2 North America Bevacizumab Revenue (2016-2026)
    4.3 Europe Bevacizumab Revenue (2016-2026)
    4.4 Asia-Pacific Bevacizumab Revenue (2016-2026)
    4.5 South America Bevacizumab Revenue (2016-2026)
    4.6 Middle East and Africa Bevacizumab Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Bevacizumab Sales in Volume by Type (2016-2026)
    5.2 Global Bevacizumab Revenue by Type (2016-2026)
    5.3 Global Bevacizumab Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Bevacizumab Sales in Volume by Application (2016-2026)
    6.2 Global Bevacizumab Revenue by Application (2016-2026)
    6.3 Global Bevacizumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Bevacizumab Sales by Type (2016-2026)
    7.2 North America Bevacizumab Sales by Application (2016-2026)
    7.3 North America Bevacizumab Market Size by Country
        7.3.1 North America Bevacizumab Sales in Volume by Country (2016-2026)
        7.3.2 North America Bevacizumab Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Bevacizumab Sales by Type (2016-2026)
    8.2 Europe Bevacizumab Sales by Application (2016-2026)
    8.3 Europe Bevacizumab Market Size by Country
        8.3.1 Europe Bevacizumab Sales in Volume by Country (2016-2026)
        8.3.2 Europe Bevacizumab Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Bevacizumab Sales by Type (2016-2026)
    9.2 Asia-Pacific Bevacizumab Sales by Application (2016-2026)
    9.3 Asia-Pacific Bevacizumab Market Size by Region
        9.3.1 Asia-Pacific Bevacizumab Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Bevacizumab Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Bevacizumab Sales by Type (2016-2026)
    10.2 South America Bevacizumab Sales by Application (2016-2026)
    10.3 South America Bevacizumab Market Size by Country
        10.3.1 South America Bevacizumab Sales in Volume by Country (2016-2026)
        10.3.2 South America Bevacizumab Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Bevacizumab Sales by Type (2016-2026)
    11.2 Middle East & Africa Bevacizumab Sales by Application (2016-2026)
    11.3 Middle East & Africa Bevacizumab Market Size by Country
        11.3.1 Middle East & Africa Bevacizumab Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Bevacizumab Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Bevacizumab Typical Distributors
    12.3 Bevacizumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

List of Tables Table 1. Global Bevacizumab Revenue by Type, (USD Million), 2021-2026 Table 2. Global Bevacizumab Revenue by Application, (USD Million), 2021-2026 Table 3. Genentech Basic Information, Manufacturing Base and Competitors Table 4. Genentech Major Business Table 5. Genentech Bevacizumab Product and Services Table 6. Genentech Bevacizumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Amgen Basic Information, Manufacturing Base and Competitors Table 8. Amgen Major Business Table 9. Amgen Bevacizumab Product and Services Table 10. Amgen Bevacizumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 11. Global Bevacizumab Sales by Manufacturer (2019-2021e) & (K Units) Table 12. Global Bevacizumab Revenue by Manufacturer (2019-2021e) & (USD Million) Table 13. Market Position of Manufacturers in Bevacizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 14. Global Bevacizumab Production Capacity by Company, (K Units): 2020 VS 2021 Table 15. Head Office and Bevacizumab Production Site of Key Manufacturer Table 16. Global Bevacizumab Sales by Region (2016-2021e) & (K Units) Table 17. Global Bevacizumab Sales by Region (2021-2026) & (K Units) Table 18. Global Bevacizumab Revenue by Region (2016-2021e) & (USD Million) Table 19. Global Bevacizumab Revenue by Region (2021-2026) & (USD Million) Table 20. Global Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 21. Global Bevacizumab Sales by Type (2021-2026) & (K Units) Table 22. Global Bevacizumab Revenue by Type (2016-2021e) & (USD Million) Table 23. Global Bevacizumab Revenue by Type (2021-2026) & (USD Million) Table 24. Global Bevacizumab Price by Type (2016-2021e) & (USD/Unit) Table 25. Global Bevacizumab Price by Type (2021-2026) & (USD/Unit) Table 26. Global Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 27. Global Bevacizumab Sales by Application (2021-2026) & (K Units) Table 28. Global Bevacizumab Revenue by Application (2016-2021e) & (USD Million) Table 29. Global Bevacizumab Revenue by Application (2021-2026) & (USD Million) Table 30. Global Bevacizumab Price by Application (2016-2021e) & (USD/Unit) Table 31. Global Bevacizumab Price by Application (2021-2026) & (USD/Unit) Table 32. North America Bevacizumab Sales by Country (2016-2021e) & (K Units) Table 33. North America Bevacizumab Sales by Country (2021-2026) & (K Units) Table 34. North America Bevacizumab Revenue by Country (2016-2021e) & (USD Million) Table 35. North America Bevacizumab Revenue by Country (2021-2026) & (USD Million) Table 36. North America Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 37. North America Bevacizumab Sales by Type (2021-2026) & (K Units) Table 38. North America Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 39. North America Bevacizumab Sales by Application (2021-2026) & (K Units) Table 40. Europe Bevacizumab Sales by Country (2016-2021e) & (K Units) Table 41. Europe Bevacizumab Sales by Country (2021-2026) & (K Units) Table 42. Europe Bevacizumab Revenue by Country (2016-2021e) & (USD Million) Table 43. Europe Bevacizumab Revenue by Country (2021-2026) & (USD Million) Table 44. Europe Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 45. Europe Bevacizumab Sales by Type (2021-2026) & (K Units) Table 46. Europe Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 47. Europe Bevacizumab Sales by Application (2021-2026) & (K Units) Table 48. Asia-Pacific Bevacizumab Sales by Region (2016-2021e) & (K Units) Table 49. Asia-Pacific Bevacizumab Sales by Region (2021-2026) & (K Units) Table 50. Asia-Pacific Bevacizumab Revenue by Region (2016-2021e) & (USD Million) Table 51. Asia-Pacific Bevacizumab Revenue by Region (2021-2026) & (USD Million) Table 52. Asia-Pacific Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 53. Asia-Pacific Bevacizumab Sales by Type (2021-2026) & (K Units) Table 54. Asia-Pacific Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 55. Asia-Pacific Bevacizumab Sales by Application (2021-2026) & (K Units) Table 56. South America Bevacizumab Sales by Country (2016-2021e) & (K Units) Table 57. South America Bevacizumab Sales by Country (2021-2026) & (K Units) Table 58. South America Bevacizumab Revenue by Country (2016-2021e) & (USD Million) Table 59. South America Bevacizumab Revenue by Country (2021-2026) & (USD Million) Table 60. South America Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 61. South America Bevacizumab Sales by Type (2021-2026) & (K Units) Table 62. South America Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 63. South America Bevacizumab Sales by Application (2021-2026) & (K Units) Table 64. Middle East & Africa Bevacizumab Sales by Country (2016-2021e) & (K Units) Table 65. Middle East & Africa Bevacizumab Sales by Country (2021-2026) & (K Units) Table 66. Middle East & Africa Bevacizumab Revenue by Country (2016-2021e) & (USD Million) Table 67. Middle East & Africa Bevacizumab Revenue by Country (2021-2026) & (USD Million) Table 68. Middle East & Africa Bevacizumab Sales by Type (2016-2021e) & (K Units) Table 69. Middle East & Africa Bevacizumab Sales by Type (2021-2026) & (K Units) Table 70. Middle East & Africa Bevacizumab Sales by Application (2016-2021e) & (K Units) Table 71. Middle East & Africa Bevacizumab Sales by Application (2021-2026) & (K Units) Table 72. Direct Channel Pros & Cons Table 73. Indirect Channel Pros & Cons Table 74. Bevacizumab Typical Distributors Table 75. Bevacizumab Typical Customers List of Figures Figure 1. Bevacizumab Picture Figure 2. Global Bevacizumab Sales Market Share by Type in 2020 Figure 3. Avastin (bevacizumab) Figure 4. Mvasi (bevacizumab-awwb) Figure 5. Global Bevacizumab Sales Market Share by Application in 2020 Figure 6. Cancer Figure 7. Eye Diease Figure 8. Global Bevacizumab Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026 Figure 9. Global Bevacizumab Market Size and Forecast (2016-2026) & (USD Million) Figure 10. United States Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 11. Canada Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 12. Mexico Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 13. Germany Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 14. France Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 15. United Kingdom Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 16. Russia Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 17. Italy Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 18. China Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 19. Japan Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 20. Korea Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 21. India Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 22. Southeast Asia Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 23. Australia Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 24. Brazil Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 25. Egypt Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 26. Saudi Arabia Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 27. South Africa Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 28. Turkey Bevacizumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 29. Global Bevacizumab Sales (2016-2026) & (K Units) Figure 30. Global Bevacizumab Production Capacity (2016-2026) & (K Units) Figure 31. Global Bevacizumab Production Capacity by Geographic Region: 2020 VS 2021 Figure 32. Bevacizumab Market Drivers Figure 33. Bevacizumab Market Restraints Figure 34. Bevacizumab Market Trends Figure 35. Global Bevacizumab Sales Market Share by Manufacturer in 2020 Figure 36. Global Bevacizumab Revenue Market Share by Manufacturer in 2020 Figure 37. Bevacizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 38. Top 3 Bevacizumab Manufacturer (Revenue) Market Share in 2020 Figure 39. Top 6 Bevacizumab Manufacturer (Revenue) Market Share in 2020 Figure 40. Global Bevacizumab Sales Market Share by Region (2016-2026) Figure 41. Global Bevacizumab Revenue Market Share by Region (2016-2026) Figure 42. North America Bevacizumab Revenue (2016-2026) & (USD Million) Figure 43. Europe Bevacizumab Revenue (2016-2026) & (USD Million) Figure 44. Asia-Pacific Bevacizumab Revenue (2016-2026) & (USD Million) Figure 45. South America Bevacizumab Revenue (2016-2026) & (USD Million) Figure 46. Middle East & Africa Bevacizumab Revenue (2016-2026) & (USD Million) Figure 47. Global Bevacizumab Sales Market Share by Type (2016-2026) Figure 48. Global Bevacizumab Revenue Market Share by Type (2016-2026) Figure 49. Global Bevacizumab Price by Type (2016-2026) & (USD/Unit) Figure 50. Global Bevacizumab Sales Market Share by Application (2016-2026) Figure 51. Global Bevacizumab Revenue Market Share by Application (2016-2026) Figure 52. Global Bevacizumab Price by Application (2016-2026) & (USD/Unit) Figure 53. North America Bevacizumab Sales Market Share by Country (2016-2026) Figure 54. North America Bevacizumab Revenue Market Share by Country (2016-2026) Figure 55. North America Bevacizumab Sales Market Share by Type (2016-2026) Figure 56. North America Bevacizumab Sales Market Share by Application (2016-2026) Figure 57. Europe Bevacizumab Sales Market Share by Country (2016-2026) Figure 58. Europe Bevacizumab Revenue Market Share by Country (2016-2026) Figure 59. Europe Bevacizumab Sales Market Share by Type (2016-2026) Figure 60. Europe Bevacizumab Sales Market Share by Application (2016-2026) Figure 61. Asia-Pacific Bevacizumab Sales Market Share by Region (2016-2026) Figure 62. Asia-Pacific Bevacizumab Revenue Market Share by Region (2016-2026) Figure 63. Asia-Pacific Bevacizumab Sales Market Share by Region (2016-2026) Figure 64. Asia-Pacific Bevacizumab Sales Market Share by Application (2016-2026) Figure 65. South America Bevacizumab Sales Market Share by Country (2016-2026) Figure 66. South America Bevacizumab Revenue Market Share by Country (2016-2026) Figure 67. South America Bevacizumab Sales Market Share by Type (2016-2026) Figure 68. South America Bevacizumab Sales Market Share by Application (2016-2026) Figure 69. Middle East & Africa Bevacizumab Sales Market Share by Country (2016-2026) Figure 70. Middle East & Africa Bevacizumab Revenue Market Share by Country (2016-2026) Figure 71. Middle East & Africa Bevacizumab Sales Market Share by Type (2016-2026) Figure 72. Middle East & Africa Bevacizumab Sales Market Share by Application (2016-2026) Figure 73. Sales Channel: Direct Channel vs Indirect Channel Figure 74. Methodology Figure 75. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us